Orthocell wins first international approval for nerve repair product
West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences Authority in Singapore.
LC2
0.00%
0.0¢
LATITUDE AUSTRALIA PERSONAL LOANS SERIES 2020-1 TRUST - News & Media
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No News & Media currently available.